Emami Q2 FY27: PAT ₹138.9 Cr & Rev ₹1,039 Cr

1 Financial Results 🔴 High Importance Neutral 📄 PDF

Metric	Value
Revenue	₹1,039 Cr
Net Profit (PAT)	₹138.9 Cr

📢 Key Event
Emami reports 15% consolidated revenue growth to ₹1,039 crore in Q1FY27

🔄 What Changed
Consolidated revenue +15% YoY to ₹1,039 crore; EBITDA +6% to ₹226 crore; International revenue -12%; Strategic investments now 18% of domestic business

🔮 What's Next
Q2FY27 expected to benefit from healthy demand trends and continued momentum in strategic investment businesses; commodity inflation and geopolitical developments remain key monitorables

💡 Investor Takeaway
Emami delivered strong revenue and EBITDA growth despite inflation and geopolitical headwinds, with strategic investments emerging as a key growth driver contributing 18% of domestic business.

Emami Limited reported consolidated revenue of ₹1,039 crore for Q1FY27, up 15% year-on-year, driven by 20% growth in domestic business and 11% growth in hair and scalp care. EBITDA rose 6% to ₹226 crore despite 360 basis point margin compression to 65.8% due to elevated input costs. Strategic investments in Axiom Ayurveda and IncNut strengthened new-age growth engines, now contributing 18% of domestic business. International revenue declined 12% due to West Asia disruptions. The company maintained optimism for Q2FY27, citing resilient demand and digital transformation initiatives.

2 Financial Results 🔴 High Importance Neutral 📄 PDF

📢 Key Event
Emami reports 15% consolidated revenue growth to ₹1,039 crore in Q1FY27

🔄 What Changed
Consolidated revenue +15% YoY to ₹1,039 crore; EBITDA +6% to ₹226 crore; gross margins down 360 bps to 65.8%; International revenue -12%; Strategic investments now 18% of domestic business

🔮 What's Next
Q2FY27 expected to benefit from healthy demand trends and continued momentum in strategic investment businesses; commodity inflation and geopolitical developments remain key monitorables

💡 Investor Takeaway
Emami delivered resilient growth amid inflation and geopolitical headwinds, with strategic investments emerging as a key growth driver while maintaining profitability discipline.

Emami Limited reported consolidated revenue of ₹1,039 crore for Q1FY27, up 15% year-on-year, driven by 20% growth in domestic business and 11% growth in hair and scalp care. EBITDA rose 6% to ₹226 crore despite 360 basis points of gross margin compression to 65.8% due to elevated input costs. Strategic investments in Axiom Ayurveda and IncNut strengthened new-age growth engines, now contributing 18% of domestic business. International revenue declined 12% due to West Asia disruptions, but the company remains confident in Q2FY27 momentum.

📊 Stock Analysis — EMAMILTD ✨ Ask AI About This

About Emami Limited (EMAMILTD)

Fast Moving Consumer Goods · Personal Products · Listed on NSE

Market Cap: ₹18,684.38 Cr P/E: 23.6

View full EMAMILTD stock details →

📡 Get AI alerts when EMAMILTD files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track EMAMILTD — Free

💡 Ask AI about this filing

"How does 18% contribution from strategic investments impact long-term margin trajectory?" "What specific cost optimization measures drove 6% EBITDA growth amid 360 bps margin compression?" "When will international business regain momentum after the 12% decline?"

Ask AI Free →

📊 More EMAMILTD filings

See all EMAMILTD filings →

🔥 Also filed on 4 August 2026

JYOTISTRUC Jyoti Structures Limited Financial Results PRICOLLTD Pricol Limited Financial Results VRLLOG VRL Logistics Limited Financial Results WORTHPERI Worth Peripherals Limited Financial Results UNIMECH Unimech Aerospace and Manufacturing Limited Annual Report KNRCON KNR Constructions Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when EMAMILTD files new disclosures

Track EMAMILTD filings, board meetings, and corporate actions. Free email alerts at 5 PM.